메뉴보기
    HOME

    SEARCH

    • up
    • down
    [NEWS] Dr. Howard Lee at the 37th KCR Annual Scientific Meeting
    [NEWS] AI to patient eligibility assessment for clinical trials
    [NEWS] The evolution of the regulatory agency
    [NEWS] How to design safe, scientific, efficient, and practical early phase clinical trials
    [NEWS] CCADD website is now official!
    [PUBLICATIONS]

    Oh J, Ji S, Lee H, Yu KS, Jang IJ. Response to "Induction of both P-glycoprotein and specific cytochrome P450 by Aspirin eventually does not alter the antithrombotic effect of clopidogrel". Clin. Pharmacol. Ther. 2015;97(4):325

    [PUBLICATIONS]

    Lee H, Kim KS, Chae SC, Jeong MH, Kim DS, Oh BH. Ambulatory Blood Pressure Response to Once-Daily Fimasartan: An 8-Week, Multicenter, Randomized, Double-Blind, Active-Comparator, Parallel-Group Study in Korean Patients With Mild To Moderate Essential Hypertension. Clin Ther. 2013;35(9):1337-49. doi: 10.1016/j.clinthera.2013.06.021.

    [PUBLICATIONS]

    Lee HA, Leavens TL, Mason SE, Monteiro-Riviere NA, Riviere JE. Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model. Nano Letters. 2009 Feb;9(2):794-9. doi: 10.1021/nl803481q.

    [PUBLICATIONS]

    Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H. Suboptimal Aminoglycoside Dosing in Critically Ill Patients, Ther Drug Monit, 2008;30:674–681.

    [PEOPLE] Heechan Lee, MS, RPh

    CCADD

    Center for Convergence Approaches in Drug Development, Graduate School of Convergence Science and Technology, Seoul National University

    Room C-208, 145 Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16229, SOUTH KOREA (Gwanggyo)

    Room 406, Building 17, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, SOUTH KOREA (Yeon-gun)

    Tel: +82-31-888-9189 (Gwanggyo); +82-2-3668-7381 (Yeon-gun)

    Fax: +82-31-888-9575

    Email: ccadd.snu@gmail.com